Rating History for Rani Therapeutics (RANI) by Chardan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/18/2026 | Andreas Argyrides | New Coverage | Buy (N/A) |
6.00 (N/A) |
0.80 (0.86) |
7.5% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/18/2026 | Andreas Argyrides | New Coverage | Buy (N/A) |
6.00 (N/A) |
0.80 (0.86) |
7.5% | Details |